NewsRx

Search our medical news database

Chimicles & Tikellis LLP

Securities class action filed against Discovery Laboratories, Inc.

Published in Elder Law Weekly, June 14th, 2006

Chimicles & Tikellis LLP and Durant & Durant, LLP have commenced a securities class action against Discovery Laboratories, Inc. (DSCO) (Discovery Labs or the company), Robert J. Capetola, its chief executive officer, and Christopher J. Schaber, its former chief operating officer, in the United States District Court for the Eastern District of Pennsylvania.

The action, DePace v. Discovery Laboratories, Inc., No. 06-02045(SD), was brought on behalf of all persons who purchased common stock of Discovery Labs between February 1, 2005 and April 24, 2006 (the Class). Excluded from the Class are defendants, members of their families, and the directors and officers of Discovery...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Elder Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook